{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:05:49Z","timestamp":1792371949511,"version":"4.4.0"},"reference-count":307,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/10173-6"],"award-info":[{"award-number":["2019\/10173-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01132","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T11:11:15Z","timestamp":1595589075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":282,"title":["From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery"],"prefix":"10.3389","volume":"11","author":[{"given":"Karla de Castro Figueiredo","family":"Bordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Takeno","family":"Cologna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Corr\u00eaa","family":"Fornari-Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto Lopes","family":"Pinheiro-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Augusto","family":"Cerni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Gobbi","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Antonio Pino","family":"Anjolette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francielle Almeida","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Adriano","family":"Wiezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara Aim\u00ea","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Gobbo","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora Sousa de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johara","family":"Boldrini-Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela Berto","family":"Pucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Amaral","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane Candiani","family":"Arantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/0250-474X.115456","article-title":"Leech therapeutic applications","volume":"75","author":"Abdualkader","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13550-016-0175-x","article-title":"Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors","volume":"6","author":"Accardo","year":"2016","journal-title":"EJNMMI Res."},{"key":"B3","unstructured":"RPI-78M2018"},{"key":"B4","unstructured":"RPI-MN2020"},{"key":"B5","first-page":"69","article-title":"Studies on bee venom and its medical uses","volume":"1","author":"Ali","year":"2012","journal-title":"Int. J. Adv. Res. Technol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1074\/jbc.M110.167718","article-title":"Losac, the first hemolin that exhibits procogulant activity through selective factor X proteolytic activation","volume":"286","author":"Alvarez-Flores","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxicon.2017.06.001","article-title":"Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster","volume":"135","author":"Alves","year":"2017","journal-title":"Toxicon"},{"key":"B8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/j.1464-410X.2008.07762.x","article-title":"Penile erection induced in vivo by a purified toxin from the Brazilian spider Phoneutria nigriventer","volume":"102","author":"Andrade","year":"2008","journal-title":"BJU Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000048075","article-title":"Lonomia genus caterpillar envenomation: Clinical and biological aspects","volume":"31","author":"Arocha-Pinango","year":"2001","journal-title":"Haemostasis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/md15120393","article-title":"Biotechnological and pharmacological applications of biotoxins and other bioactive molecules from dinoflagellates","volume":"15","author":"Assuncao","year":"2017","journal-title":"Mar. Drugs"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1159\/000366366","article-title":"Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles","volume":"34","author":"Badr","year":"2014","journal-title":"Cell Physiol. Biochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11307-017-1151-1","article-title":"Prostate cancer theranostics targeting gastrin-releasing peptide receptors","volume":"20","author":"Baratto","year":"2018","journal-title":"Mol. Imaging Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/10937400903442514","article-title":"A new fibrin sealant from Crotalus durissus terrificus venom: applications in medicine","volume":"12","author":"Barros","year":"2009","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"B14","volume-title":"Pharmaceutical composition containing an Apitoxin fraction and use thereof","author":"Bastos","year":"2011"},{"key":"B15","unstructured":"Discontinuation of Refludan\u00ae\u00a0[lepirudin (rDNA) for injection]2012"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/B978-0-12-385095-9.00064-6","article-title":"Targets and therapeutic properties","volume-title":"Handbook of biologically active peptides","author":"Beeton","year":"2013"},{"key":"B18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1573399811309020007","article-title":"Evolution of exenatide as a diabetes therapeutic","volume":"9","author":"Bhavsar","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"B19","unstructured":"Pepteron (RPI-MN)2007"},{"key":"B20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/clpt.1981.92","article-title":"Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I","volume":"29","author":"Biollaz","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"B21","unstructured":"First clinical trial sponsored by Biozeus concluded!2018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1755-1536-4-3","article-title":"Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis","volume":"4","author":"Bitencourt","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1067\/mhj.2001.119374","article-title":"Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study","volume":"142","author":"Bittl","year":"2001","journal-title":"Am. Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1007\/s00253-015-6836-2","article-title":"Expression of a new serine protease from Crotalus durissus collilineatus venom in Pichia pastoris and functional comparison with the native enzyme","volume":"99","author":"Boldrini-Fran\u00e7a","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.bbagen.2016.12.022","article-title":"Minor snake venom proteins: Structure, function and potential applications","volume":"1861","author":"Boldrini-Fran\u00e7a","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e147118","DOI":"10.1590\/1678-9199-jvatitd-1741-18","article-title":"Functional and biological insights of rCollinein-1, a recombinant serine protease from Crotalus durissus collilineatus","volume":"25","author":"Boldrini-Franca","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61258-x","article-title":"Beyond hemostasis: a snake venom serine protease with potassium channel blocking and potential antitumor activities","volume":"10","author":"Boldrini-Fran\u00e7a","year":"2020","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/j.1398-9995.2005.00960.x","article-title":"Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice","volume":"60","author":"Bonifazi","year":"2005","journal-title":"Allergy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058866","article-title":"In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin","volume":"8","author":"Bowen","year":"2013","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0300-9084(00)01178-0","article-title":"Snake venom proteins acting on hemostasis","volume":"82","author":"Braud","year":"2000","journal-title":"Biochimie"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1097\/j.pain.0000000000000669","article-title":"Crotalphine desensitizes TRPA1 ion channels to alleviate inflammatory hyperalgesia","volume":"157","author":"Bressan","year":"2016","journal-title":"Pain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pbb.2013.04.012","article-title":"Peripheral kappa and delta opioid receptors are involved in the antinociceptive effect of crotalphine in a rat model of cancer pain","volume":"109","author":"Brigatte","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1073\/pnas.80.5.1463","article-title":"Botrocetin (venom coagglutinin) - Reaction with a broad-spectrum of multimeric forms of factor VIII macromolecular complex","volume":"80","author":"Brinkhous","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A. -Biol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2165\/00003495-198836050-00003","article-title":"Captopril - an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart-failure","volume":"36","author":"Brogden","year":"1988","journal-title":"Drugs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1021\/jm9003413","article-title":"\u03c7-conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain","volume":"52","author":"Brust","year":"2009","journal-title":"J. Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e20190038","DOI":"10.1590\/1678-9199-jvatitd-2019-0038","article-title":"Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review","volume":"25","author":"Buchaim","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0014-5793(92)80559-Y","article-title":"Amino acid sequence determination of ancrod, the thrombin-like alpha-fibrinogenase from the venom of Agkistrodon rhodostoma","volume":"297","author":"Burkhart","year":"1992","journal-title":"FEBS Lett."},{"key":"B38","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/2013.11.FOCUS13497","article-title":"Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors","volume":"36","author":"Butte","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"B39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.toxicon.2011.07.013","article-title":"Bradykinin-potentiating peptides: Beyond captopril","volume":"59","author":"Camargo","year":"2012","journal-title":"Toxicon"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10616-014-9740-1","article-title":"Discovery of a new antiviral protein isolated Lonomia obliqua analysed by bioinformatics and real-time approaches","volume":"67","author":"Carmo","year":"2015","journal-title":"Cytotechnology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2967\/jnumed.107.045054","article-title":"Bombesin receptor antagonists may be preferable to agonists for tumor targeting","volume":"49","author":"Cescato","year":"2008","journal-title":"J. Nucl. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1007\/s00253-016-7610-9","article-title":"Snake venom toxins: toxicity and medicinal applications","volume":"100","author":"Chan","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01247","article-title":"Involvement of acid-sensing ion channel 1b in the development of acid-induced chronic muscle pain","volume":"13","author":"Chang","year":"2019","journal-title":"Front. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1073\/pnas.1614728114","article-title":"Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a","volume":"114","author":"Chassagnon","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1039\/c6an00327c","article-title":"A single-label fluorescent derivatization method for quantitative determination of neurotoxin in vivo by capillary electrophoresis coupled with laser-induced fluorescence detection","volume":"141","author":"Chen","year":"2016","journal-title":"Analyst"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-3-11","article-title":"Adaptive design methods in clinical trials - a review","volume":"3","author":"Chow","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"B47","first-page":"503","article-title":"Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus","volume":"12","author":"Christensen","year":"2009","journal-title":"Idrugs"},{"key":"B48","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1002\/anie.201000620","article-title":"The engineering of an orally active conotoxin for the treatment of neuropathic pain","volume":"49","author":"Clark","year":"2010","journal-title":"Angew. Chem. Int. Ed"},{"key":"B49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tibs.2018.12.004","article-title":"Friends or foes? Emerging impacts of biological toxins","volume":"44","author":"Clark","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jocn.2016.04.012","article-title":"Glioblastoma multiforme targeted therapy: The Chlorotoxin story","volume":"33","author":"Cohen-Inbar","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jtcme.2016.11.005","article-title":"Exploiting leech saliva to treat osteoarthritis: A provocative perspective","volume":"7","author":"Cooper","year":"2017","journal-title":"J. Tradit. Complement Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1021\/bi00644a014","article-title":"Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids","volume":"16","author":"Cushman","year":"1977","journal-title":"Biochemistry"},{"key":"B53","unstructured":"DalyJ. Chlorine compound of the month: Eptibatidine - natural frog poison with a surprising benefit to humans2004"},{"key":"B54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.leukres.2006.06.004","article-title":"Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562","volume":"31","author":"Das Gupta","year":"2007","journal-title":"Leuk. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2174\/0929866522666151013130742","article-title":"PEGylation: A successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease","volume":"22","author":"da-Silva-Freitas","year":"2015","journal-title":"Protein Pept. Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.peptides.2014.09.024","article-title":"Mastoparan induces apoptosis in B1 6F10-Nex2 melanoma cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo","volume":"68","author":"de Azevedo","year":"2015","journal-title":"Peptides"},{"key":"B57","doi-asserted-by":"publisher","first-page":"14739","DOI":"10.1038\/s41598-018-33133-3","article-title":"CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells","volume":"8","author":"de Oliveira-Mendes","year":"2018","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/0041-0101(91)90128-E","article-title":"Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus","volume":"29","author":"DeBin","year":"1991","journal-title":"Toxicon"},{"key":"B59","doi-asserted-by":"publisher","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am. J. Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1089\/dia.2011.0050","article-title":"Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes","volume":"13","author":"DeYoung","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1535370213513991","article-title":"Scorpion venoms as a potential source of novel cancer therapeutic compounds","volume":"239","author":"Ding","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature11494","article-title":"Black mamba venom peptides target acid-sensing ion channels to abolish pain","volume":"490","author":"Diochot","year":"2012","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0014-5793(84)80165-9","article-title":"The complete amino acid sequence of hirudin, a thrombin specific inhibitor. Application of colour carboxymethylation","volume":"165","author":"Dodt","year":"1984","journal-title":"FEBS"},{"key":"B64","unstructured":"Nutra Pharma announces manufacturing alliance with Omnia Biologics to produce RPI-78M for clinical trials in pediatric multiple sclerosis2016"},{"key":"B65","unstructured":"Search2020"},{"key":"B66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/md15100303","article-title":"Guanidinium toxins and their interactions with voltage-gated sodium ion channels","volume":"15","author":"Duran-Riveroll","year":"2017","journal-title":"Mar Drugs"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.irn.2017.08.006","article-title":"Current strategies for the delivery of therapeutic proteins and enzymes to treat brain disorders","volume":"137","author":"Duskey","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1042\/bst026s283","article-title":"Molecular modelling of batroxobin on kallikreins","volume":"26","author":"Earps","year":"1998","journal-title":"Biochem. Soc. Trans."},{"key":"B69","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40265-013-0033-3","article-title":"Lixisenatide: First global approval","volume":"73","author":"Elkinson","year":"2013","journal-title":"Drugs"},{"key":"B70","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00228-003-0565-7","article-title":"Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects","volume":"59","author":"Eriksson","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1047\/jbc.M412521200","article-title":"Transduction of the scorpion toxin maurocalcine into cells - Evidence that the toxin crosses the plasma membrane","volume":"280","author":"Esteve","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B73","unstructured":"Search for medicines: Search our database of medicines - including human medicines, veterinary medicines and herbal medicines2020"},{"key":"B74","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/PAT.0000000000000142","article-title":"Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines","volume":"46","author":"Favaloro","year":"2014","journal-title":"Pathology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40264-013-0132-9","article-title":"Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network","volume":"37","author":"Ferrajolo","year":"2014","journal-title":"Drug Saf."},{"key":"B76","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF02144709","article-title":"Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom","volume":"21","author":"Ferreira","year":"1965","journal-title":"Experientia"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1021\/bi00815a005","article-title":"Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom","volume":"9","author":"Ferreira","year":"1970","journal-title":"Biochemistry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/225379a0","article-title":"Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme","volume":"225","author":"Ferreira","year":"1970","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40409-017-0109-8","article-title":"Heterologous fibrin sealant derived from snake venom: from bench to bedside - an overview","volume":"23","author":"Ferreira","year":"2017","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","article-title":"A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca","volume":"24","author":"Ferreira","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0146-0005(00)80046-4","article-title":"Angiotensin converting enzyme: history and relevance","volume":"24","author":"Ferreira","year":"2000","journal-title":"Semin. Perinatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.2174\/138161207782023739","article-title":"Approaching the golden age of natural product pharmaceuticals from venom libraries: An overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications","volume":"13","author":"Fox","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B83","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/B978-0-12-813726-0.00164-1","article-title":"Diagnostic use of venoms","volume-title":"Transfusion Medicine and Hemostasis","author":"Francischetti","year":"2019"},{"key":"B84","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2006.10.056","article-title":"Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas","volume":"412","author":"Fu","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10529-011-0741-2","article-title":"A potential strategy for high-grade gliomas: combination treatment with lithium chloride and BmK CT","volume":"34","author":"Fu","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"B86","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s10637-017-0438-z","article-title":"First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors","volume":"35","author":"Fu","year":"2017","journal-title":"Invest. New Drugs"},{"key":"B87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2141.1971.tb03415.x","article-title":"Reptilase\u00ae - a new reagent in blood coagulation","volume":"21","author":"Funk","year":"1971","journal-title":"Br. J. Haematol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.toxicon.2010.12.016","article-title":"The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent","volume":"59","author":"Furman","year":"2012","journal-title":"Toxicon"},{"key":"B89","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.etap.2013.06.009","article-title":"Melittin: A lytic peptide with anticancer properties","volume":"36","author":"Gajski","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B90","doi-asserted-by":"crossref","first-page":"19827","DOI":"10.1016\/S0021-9258(19)77710-2","article-title":"). Echistatin. A potent platelet aggregation inhibitor from the venom of the viper Echis carinatus","volume":"263","author":"Gan","year":"1988","journal-title":"J. Biol. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/toxins9120397","article-title":"Cone snails: a big store of conotoxins for novel drug discovery","volume":"9","author":"Gao","year":"2017","journal-title":"Toxins"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1586\/14737175.2014.962518","article-title":"Venom-based biotoxins as potential analgesics","volume":"14","author":"Gazerani","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10989-018-9721-x","article-title":"Scorpion venom-toxins that aid in drug development: a review","volume":"25","author":"Ghosh","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/molecules22101743","article-title":"Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries","volume":"22","author":"Gomes","year":"2017","journal-title":"Molecules"},{"key":"B95","unstructured":"GotterA. Apitherapy2019"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1586\/erc.11.131","article-title":"Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis","volume":"9","author":"Graetz","year":"2011","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/2152-7806.156871","article-title":"Autologous fibrin sealant (Vivostat\u00ae) in the neurosurgical practice: Part I: Intracranial surgical procedure","volume":"6","author":"Graziano","year":"2015","journal-title":"Surg. Neurol. Int."},{"key":"B98","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.4103\/2152-7806.174894","article-title":"Aulogous fibrin sealant (Vivostat\u00ae) in the neurosurgical practice: Part II: Vertebro-spinal procedures","volume":"7","author":"Graziano","year":"2016","journal-title":"Surg. Neurol. Int."},{"key":"B99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s001250051111","article-title":"Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations","volume":"42","author":"Greig","year":"1999","journal-title":"Diabetologia"},{"key":"B100","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ana.21949","article-title":"Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain","volume":"67","author":"Grishin","year":"2010","journal-title":"Ann. Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2146\/ajhp040534","article-title":"Ximelagatran: An orally active direct thrombin inhibitor","volume":"62","author":"Gulseth","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B102","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2008.07.053","article-title":"Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors","volume":"594","author":"Gutierrez","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.2174\/138161208785777469","article-title":"Conus venoms - A rich source of peptide-based therapeutics","volume":"14","author":"Han","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.2147\/cia.s84940","article-title":"The beneficial effects of honeybee-venom serum on facial wrinkles in humans","volume":"10","author":"Han","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1021\/jm00102a020","article-title":"Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors","volume":"35","author":"Hartman","year":"1992","journal-title":"J. Med. Chem."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158235","article-title":"Bee venom for the treatment of Parkinson disease - A randomized controlled clinical trial","volume":"11","author":"Hartmann","year":"2016","journal-title":"PloS One"},{"key":"B107","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.toxicon.2014.10.020","article-title":"Toxins and drug discovery","volume":"92","author":"Harvey","year":"2014","journal-title":"Toxicon"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(06)69776-6","article-title":"Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial","volume":"368","author":"Hennerici","year":"2006","journal-title":"Lancet"},{"key":"B109","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jdiacomp.2013.12.009","article-title":"Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes","volume":"28","author":"Henry","year":"2014","journal-title":"J. Diabetes Complicat."},{"key":"B110","first-page":"580","article-title":"Imaging glioma extent with 131I-TM-601","volume":"46","author":"Hockaday","year":"2005","journal-title":"J. Nucl. Med."},{"key":"B111","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0021-9258(17)33700-6","article-title":"The thrombin-like enzyme from Bothrops atrox snake venom. Properties of the enzyme purified by affinity chromatography on p-aminobenzamidine-substituted agarose","volume":"251","author":"Holleman","year":"1976","journal-title":"J. Biol. Chem."},{"key":"B112","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-017-0158-2","article-title":"Kv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in experimental autoimmune encephalomyelitis","volume":"7","author":"Huang","year":"2017","journal-title":"CellBiosci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ijpharm.2014.10.059","article-title":"Administration strategies for proteins and peptides","volume":"477","author":"Ibraheem","year":"2014","journal-title":"Int. J. Pharm."},{"key":"B114","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2018.06.002","article-title":"Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide","volume":"281","author":"Ichiki","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0014-2999(99)00616-0","article-title":"Effects of apamin on memory processing of hippocampal-lesioned mice","volume":"382","author":"Ikonen","year":"1999","journal-title":"Eur. JPharmacol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1016\/S0021-9258(18)61479-6","article-title":"Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme","volume":"262","author":"Itoh","year":"1987","journal-title":"J. Biol. Chem."},{"key":"B117","first-page":"39","article-title":"Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide","volume":"30","author":"Jacoby","year":"2010","journal-title":"Anticancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000505015","article-title":"Apitherapy for osteoarthritis: perspectives from basic research","volume":"27","author":"Jagua-Gualdr\u00f3n","year":"2020","journal-title":"Complement Med. Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2010.10.066","article-title":"Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo","volume":"651","author":"Jang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B120","unstructured":"Champions of Science\u00ae Storytelling Challenge: Latin America and Caribbean Edition2019"},{"key":"B121","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1055\/s-2007-1002723","article-title":"Biochemistry and genetic-engineering of hirudin","volume":"15","author":"Johnson","year":"1989","journal-title":"Semin. Thromb. Hemost."},{"key":"B122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/bc2002924","article-title":"Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: Characterization of inverso mastoparan as a highly efficient cell penetrating peptide","volume":"23","author":"Jones","year":"2012","journal-title":"Bioconj. Chem."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jocd.12492","article-title":"The use of natural ingredients in innovative Korean cosmeceuticals","volume":"17","author":"Juh\u00e1sz","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfb.2017.12.013","article-title":"Design and characterization of crotamine-functionalized gold nanoparticles","volume":"163","author":"Karpel","year":"2018","journal-title":"Colloids Surf B Biointerfaces"},{"key":"B125","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/psc.2421","article-title":"Through the looking glass - a new world of proteins enabled by chemical synthesis","volume":"18","author":"Kent","year":"2012","journal-title":"J. Pept. Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.03-1459fje","article-title":"Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus","volume":"18","author":"Kerkis","year":"2004","journal-title":"FASEB J."},{"key":"B127","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1074\/jbc.M109.066092","article-title":"Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects","volume":"285","author":"Kesavan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B128","unstructured":"KCP-506 - A novel non-opioid for the treatment of chronic pain2020"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.cell.2019.07.014","article-title":"A cell-penetrating scorpion toxin enables mode-specific modulation of TRPA1 and pain","volume":"178","author":"King","year":"2019","journal-title":"Cell"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","article-title":"Venoms as a platform for human drugs: translating toxins into therapeutics","volume":"11","author":"King","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"B131","first-page":"13","article-title":"Venoms to drugs: translating venom peptides into therapeutics","volume":"44","author":"King","year":"2013","journal-title":"Aust. Biochem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/s0003-4975(98)00470-6","article-title":"Vivostat system autologous fibrin sealant: Preliminary study in elective coronary bypass grafting","volume":"66","author":"Kjaergard","year":"1998","journal-title":"Ann. Thorac. Surg."},{"key":"B133","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/14656566.2017.1282463","article-title":"Exenatide: pharmacokinetics, clinical use, and future directions","volume":"18","author":"Knop","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"key":"B134","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/17474086.1.2.135","article-title":"Anticoagulants from hematophagous animals","volume":"1","author":"Koh","year":"2008","journal-title":"Expert Rev. Hematol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.toxicon.2011.03.017","article-title":"From snake venom toxins to therapeutics - cardiovascular examples","volume":"59","author":"Koh","year":"2012","journal-title":"Toxicon"},{"key":"B136","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s00018-006-6315-0","article-title":"Snake venom components and their applications in biomedicine","volume":"63","author":"Koh","year":"2006","journal-title":"Cell Mol. Life Sci."},{"key":"B137","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5114\/ada.2017.67082","article-title":"Safety and efficacy of venom immunotherapy: a real life study","volume":"34","author":"Kolaczek","year":"2017","journal-title":"Postepy DermatolAlergol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1526-4637.2009.00741.x","article-title":"CNSB004 (leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain","volume":"11","author":"Kolosov","year":"2010","journal-title":"Pain Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.peptides.2008.04.003","article-title":"Crotalphine, a novel potent analgesic peptide from the venom of the South American rattlesnake Crotalus durissus terrificus","volume":"29","author":"Konno","year":"2008","journal-title":"Peptides"},{"key":"B140","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1124\/pr.113.008367","article-title":"Novel delivery systems for improving the clinical use of peptides","volume":"67","author":"Kovalainen","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"B141","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ab.2013.05.013","article-title":"Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors","volume":"440","author":"Kovar","year":"2013","journal-title":"Anal. Biochem."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2741\/4461","article-title":"Antimicrobial peptides from frog skin: biodiversity and therapeutic promises","volume":"21","author":"Ladram","year":"2016","journal-title":"Front. Biosci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.3390\/md13106384","article-title":"Tetrodotoxin, an extremely potent marine neurotoxin: distribution, toxicity, origin and therapeutical uses","volume":"13","author":"Lago","year":"2015","journal-title":"Mar Drugs"},{"key":"B144","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1185\/03007995.2012.657299","article-title":"Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis","volume":"28","author":"Lang","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"B145","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br. JClin. Pharmacol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/0091270009336233","article-title":"Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects","volume":"49","author":"Lee","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006140","article-title":"Bee venom acupuncture for rheumatoid arthritis: a systematic review of randomised clinical trials","volume":"4","author":"Lee","year":"2014","journal-title":"BMJ Open"},{"key":"B148","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1124\/pr.111.005322","article-title":"Conus venom peptide pharmacology","volume":"64","author":"Lewis","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"B149","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1039\/9781849737876-00245","article-title":"Case study 1: development of the analgesic drugs Prialt\u00ae and Xen2174 from cone snail venoms","volume-title":"Venoms to drugs: venom as a source for the development of human therapeutics","author":"Lewis","year":"2015"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/849054","article-title":"The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells","volume":"2013","author":"Li","year":"2013","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006667","article-title":"Efficacy and safety of desmoteplase in acute ischemic stroke patients: A systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"B152","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/bi00001a003","article-title":"NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels","volume":"34","author":"Lippens","year":"1995","journal-title":"Biochemistry"},{"key":"B153","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jacc.2008.02.077","article-title":"). Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP","volume":"52","author":"Lisy","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1161\/STROKEAHA.111.622753","article-title":"Ancrod and fibrin formation: perspectives on mechanisms of action","volume":"42","author":"Liu","year":"2011","journal-title":"Stroke"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3892\/mmr.2015.3552","article-title":"Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells","volume":"12","author":"Liu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"B156","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1038\/s41598-018-25386-9","article-title":"Dual actions of Psalmotoxin at ASIC1a and ASIC2a heteromeric channels (ASIC1a\/2a)","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1016\/j.bmcl.2013.05.022","article-title":"Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity","volume":"23","author":"Lorenz","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9010022","article-title":"Bioactivity of natural and engineered antimicrobial peptides from venom of the scorpions Urodacus yaschenkoi and U. manicatus","volume":"9","author":"Luna-Ramirez","year":"2017","journal-title":"Toxins"},{"key":"B159","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/toxins11020131","article-title":"The role of toxins in the pursuit for novel analgesics","volume":"11","author":"Maatuf","year":"2019","journal-title":"Toxins"},{"key":"B160","volume-title":"Use of spider venoms for skin whitening\/depigmenting and composition comprising spider venoms molecules or synthetic analogs","author":"Mabrouk","year":"2018"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040968","article-title":"Co-localization of crotamine with internal membranes and accentuated accumulation in tumor cells","volume":"23","author":"Mambelli-Lisboa","year":"2018","journal-title":"Molecules"},{"key":"B162","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2015.12.044","article-title":"Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain","volume":"224","author":"Manda","year":"2016","journal-title":"J. Control Release"},{"key":"B163","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1021\/bi00482a021","article-title":"Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin","volume":"29","author":"Maraganore","year":"1990","journal-title":"Biochemistry"},{"key":"B164","doi-asserted-by":"publisher","first-page":"793","DOI":"10.3390\/toxins2040793","article-title":"Fibrolase: trials and tribulations","volume":"2","author":"Markland","year":"2010","journal-title":"Toxins"},{"key":"B165","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000216258","article-title":"Past, present and future of hirudin","author":"Markwardt","year":"1991","journal-title":"Haemostasis"},{"key":"B166","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nn1940","article-title":"A tarantula peptide against pain via ASIC1a channels and opioid mechanisms","volume":"10","author":"Mazzuca","year":"2007","journal-title":"Nat. Neurosci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1423-0410.2007.01027.x","article-title":"Platelet-rich plasma and platelet gel preparation using Plateltex\u00ae","volume":"94","author":"Mazzucco","year":"2008","journal-title":"Vox Sang"},{"key":"B168","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/nedt.2007.3.1.69","article-title":"Ziconotide: a review of its pharmacology and use in the treatment of pain","volume":"3","author":"McGivern","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"B169","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1476-5381.2011.01514.x","article-title":"Desmoteplase: discovery, insights and opportunities for ischaemic stroke","volume":"165","author":"Medcalf","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B170","unstructured":"Somerset, USAAggrastat (Tirofiban hydrochloride) injection premixed and injection prescribing information2016"},{"key":"B171","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4330\/wjc.v9.i9.761","article-title":"Safety, efficiency and cost effectiveness of Bivalirudin: A systematic review","volume":"9","author":"Mehrzad","year":"2017","journal-title":"World J. Cardiol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1002\/cncr.24602","article-title":"Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer","volume":"115","author":"Meng","year":"2009","journal-title":"Cancer"},{"key":"B173","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1155\/2014\/136419","article-title":"Comparative evaluation of recombinant protein production in different biofactories: the green perspective","volume":"2014","author":"Merlin","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"B174","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0006-8993(91)90950-z","article-title":"Effect of apamin, a toxin that inhibits Ca2+-dependent K+ channels, on learning and memory processes","volume":"551","author":"Messier","year":"1991","journal-title":"Brain Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/ijms14011370","article-title":"Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy","volume":"14","author":"Miao","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"B176","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pharmthera.2018.03.007","article-title":"Arthropod toxins and their antinociceptive properties: From venoms to painkillers","volume":"188","author":"Monge-Fuentes","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/toxins7041126","article-title":"Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan","volume":"7","author":"Moreno","year":"2015","journal-title":"Toxins"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/oxfordjournals.jbchem.a131150","article-title":"The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates","volume":"79","author":"Morita","year":"1976","journal-title":"J. Biochem."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.toxicon.2005.02.021","article-title":"Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities","volume":"45","author":"Morita","year":"2005","journal-title":"Toxicon"},{"key":"B180","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BJ20041379","article-title":"K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom","volume":"385","author":"Mouhat","year":"2005","journal-title":"Biochem. J."},{"key":"B181","doi-asserted-by":"publisher","first-page":"205929","DOI":"10.1155\/2014\/205929","article-title":"Recommendations for the use of leeches in reconstructive plastic surgery","volume":"2014","author":"Mumcuoglu","year":"2014","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"21349","DOI":"10.1074\/jbc.M604876200","article-title":"Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans","volume":"282","author":"Nascimento","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B183","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00125-006-0510-2","article-title":"A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study","volume":"50","author":"Nauck","year":"2007","journal-title":"Diabetologia"},{"key":"B184","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.toxicon.2017.02.001","article-title":"Pre-clinical evaluation of voltage-gated calcium channel blockers derived from the spider P. nigriventer in glioma progression","volume":"129","author":"Nicoletti","year":"2017","journal-title":"Toxicon"},{"key":"B185","unstructured":"NCI Drug Dictionary - TRPV6 calcium channel inhibitor SOR-C132018"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.toxicon.2008.02.010","article-title":"Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function","volume":"51","author":"Nunes","year":"2008","journal-title":"Toxicon"},{"key":"B187","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1345\/aph.1D066","article-title":"Direct thrombin inhibitors for anticoagulation","volume":"38","author":"Nutescu","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"B188","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/DMSO.S4444","article-title":"Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes","volume":"2","author":"Odegard","year":"2009","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B189","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/bip.22748","article-title":"Chlorotoxin: Structure, activity, and potential uses in cancer therapy","volume":"106","author":"Ojeda","year":"2016","journal-title":"Biopolymers"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10010008","article-title":"Computational studies of snake venom toxins","volume":"10","author":"Ojeda","year":"2018","journal-title":"Toxins"},{"key":"B191","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/bcp.13176","article-title":"Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties","volume":"83","author":"Okkerse","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"e148118","DOI":"10.1590\/1678-9199-JVATITD-1481-18","article-title":"Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression","author":"Oliveira","year":"2019","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B193","unstructured":"Medicine, cobratide for injection2019"},{"key":"B194","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.toxicon.2014.11.233","article-title":"Scorpion venom components as potential candidates for drug development","volume":"93","author":"Ortiz","year":"2015","journal-title":"Toxicon"},{"key":"B195","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/01.RVI.0000167863.10122.2A","article-title":"A phase I trial of alfimeprase for peripheral arterial thrombolysis","volume":"16","author":"Ouriel","year":"2005","journal-title":"J. Vasc. Interv. Radiol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pharmthera.2018.08.016","article-title":"Neurobiology and therapeutic applications of neurotoxins targeting transmitter release","volume":"193","author":"Ovsepian","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"B197","doi-asserted-by":"publisher","first-page":"201S","DOI":"10.1111\/j.1365-2125.1984.tb02599.x","article-title":"The chemistry of enalapril","author":"Patchett","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"E641","DOI":"10.1093\/neuros\/nyz125","article-title":"Phase 1 safety, pharmacokinetics, and fluorescence imaging study of tozuleristide (BLZ-100) in adults with newly diagnosed or recurrent gliomas","volume":"85","author":"Patil","year":"2019","journal-title":"Neurosurgery"},{"key":"B199","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxicon.2018.07.008","article-title":"Phoneutria nigriventer venom: A pharmacological treasure","volume":"151","author":"Peigneur","year":"2018","journal-title":"Toxicon"},{"key":"B200","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1124\/mol.108.052704","article-title":"Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes","volume":"75","author":"Pennington","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.bmc.2017.09.029","article-title":"Peptide therapeutics from venom: Current status and potential","volume":"26","author":"Pennington","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"B202","unstructured":"Defibrase\u00ae2018"},{"key":"B203","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.toxicon.2005.10.004","article-title":"Proteases from Lonomia obliqua venomous secretions: Comparison of procoagulant, fibrin(ogen)olytic and amidolytic activities","volume":"47","author":"Pinto","year":"2006","journal-title":"Toxicon"},{"key":"B204","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1172\/JCI107107","article-title":"Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin","volume":"51","author":"Pizzo","year":"1972","journal-title":"J. Clin. Invest."},{"key":"B205","unstructured":"PlateltexS. R. O. Czech RepublicPrahaPlateltex - Device for the activation (gelification) of blood components destined to the topical non-transfusional use2016"},{"key":"B206","unstructured":"PlateltexS. R. O. Prague, Czech RepublicPlateltex - biologicals, clinical use, information sheet2018"},{"key":"B207","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/14656566.2013.784269","article-title":"Ziconotide: a clinical update and pharmacologic review","volume":"14","author":"Pope","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"B208","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/imm.12559","article-title":"Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K+ channel pattern in T cells","volume":"147","author":"Pucca","year":"2016","journal-title":"Immunology"},{"key":"B209","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.intimp.2010.12.007","article-title":"Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor","volume":"11","author":"Qi","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.3748\/wjg.14.5210","article-title":"Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma","volume":"14","author":"Qin","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"B211","first-page":"715","article-title":"Maurocalcine-derivatives as biotechnological tools for the penetration of cell-impermeable compounds","volume-title":"Animal toxins: state of the art-perspectives in health and biotechnology","author":"Ram","year":"2009"},{"key":"B212","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pharmthera.2015.07.003","article-title":"Cell-penetrating peptides transport therapeutics into cells","volume":"154","author":"Ramsey","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"B213","volume-title":"Modified elapid venoms as stimulators of the immune reaction","author":"Reid","year":"2010"},{"key":"B214","first-page":"209","article-title":"Therapeutic defibrination by ancrod (Arvin)","volume":"95","author":"Reid","year":"1971","journal-title":"Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch."},{"key":"B215","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1615\/CritRevImmunol.v27.i4.10","article-title":"Alpha-cobratoxin as a possible therapy for multiple sclerosis: a review of the literature leading to its development for this application","volume":"27","author":"Reid","year":"2007","journal-title":"Crit. Rev. Immunol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1042\/bj20060325","article-title":"Lopap, a prothrombin activator from Lonomia obliqua belonging to the lipocalin family: recombinant production, biochemical characterization and structure-function insights","volume":"398","author":"Reis","year":"2006","journal-title":"Biochem. J."},{"key":"B217","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12975-017-0575-x","article-title":"Hi1a as a novel neuroprotective agent for ischemic stroke by inhibition of acid-sensing ion channel 1a","volume":"9","author":"Ren","year":"2018","journal-title":"Transl. Stroke Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.toxicon.2017.05.018","article-title":"The spider toxin Ph\u03b11\u03b2 recombinant possesses strong analgesic activity","volume":"133","author":"Rigo","year":"2017","journal-title":"Toxicon"},{"key":"B219","doi-asserted-by":"publisher","first-page":"E1825","DOI":"10.1073\/pnas.1621433114","article-title":"Inhibition of\u00a0\u03b19\u03b110\u00a0nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain","volume":"114","author":"Romero","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B220","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000216883","article-title":"Comparison of in vitro and in vivo properties of rhirudin (HBW 023) and a synthetic analogous peptide","volume":"23","author":"R\u00f6misch","year":"1993","journal-title":"Haemostasis"},{"key":"B221","unstructured":"Search2019"},{"key":"B222","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biom9010006","article-title":"Epibatidine: a promising natural alkaloid in health","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"key":"B223","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","article-title":"A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses","volume":"48","author":"Sample","year":"2013","journal-title":"Peptides"},{"key":"B224","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1590\/S1678-91992011000300004","article-title":"A new scenario of bioprospecting of Hymenoptera venoms through proteomic approach","volume":"17","author":"Santos","year":"2011","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B225","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40409-016-0093-4","article-title":"Exploring the in vivo wound healing effects of a recombinant hemolin from the caterpillar Lonomia obliqua","volume":"22","author":"Sato","year":"2016","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B226","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B227","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1016\/S0021-9258(18)92826-7","article-title":"Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri","volume":"266","author":"Scarborough","year":"1991","journal-title":"J. Biol. Chem."},{"key":"B228","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0021-9258(18)54042-4","article-title":"Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa","volume":"268","author":"Scarborough","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B229","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/s0002-8703(99)70075-x","article-title":"Development of eptifibatide","volume":"138","author":"Scarborough","year":"1999","journal-title":"Am. Heart J."},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam5441","article-title":"Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy","volume":"9","author":"Schechter","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B231","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10637-006-6886-5","article-title":"A phase I trial of the bombesin\/gastrin-releasing peptide (BN\/GRP) antagonist RC3095 in patients with advanced solid malignancies","volume":"24","author":"Schwartsmann","year":"2006","journal-title":"Invest. New Drugs"},{"key":"B232","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0014-2999(02)02247-1","article-title":"Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat","volume":"451","author":"Scott","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.actbio.2016.10.024","article-title":"Functional improvement of hemostatic dressing by addition of recombinant batroxobin","volume":"48","author":"Seon","year":"2017","journal-title":"Acta Biomater."},{"key":"B234","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.toxicon.2012.09.003","article-title":"The long road of research on snake venom serine proteinases","volume":"62","author":"Serrano","year":"2013","journal-title":"Toxicon"},{"key":"B235","first-page":"329","article-title":"Drug evaluation: alfimeprase, a plasminogen-independent thrombolytic","volume":"10","author":"Shah","year":"2007","journal-title":"IDrugs"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/srep33989","article-title":"Desmoteplase for acute ischemic stroke within 3 to 9\u2009Hours after symptom onset: Evidence from randomized controlled trials","volume":"6","author":"Shi","year":"2016","journal-title":"Sci. Rep."},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1186\/s40409-018-0173-8","article-title":"Deep sequencing analysis of toad Rhinella schneideri skin glands and partial biochemical characterization of its cutaneous secretion","volume":"24","author":"Shibao","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"B238","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.imr.2017.08.001","article-title":"Medicinal leech therapy - an overall perspective","volume":"6","author":"Sig","year":"2017","journal-title":"Integr. Med. Res."},{"key":"B239","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.juro.2015.06.081","article-title":"PnPP-19, a synthetic and nontoxic peptide designed from a Phoneutria nigriventer toxin, potentiates erectile function via NO\/cGMP","volume":"194","author":"Silva","year":"2015","journal-title":"J. Urol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1038\/s41598-017-04378-1","article-title":"Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities","volume":"7","author":"Singh","year":"2017","journal-title":"Sci. Rep."},{"key":"B241","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ctcp.2009.11.005","article-title":"Medicinal leech therapy (hirudotherapy): a brief overview","volume":"16","author":"Singh","year":"2010","journal-title":"Complement Ther. Clin. Pract."},{"key":"B242","doi-asserted-by":"publisher","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","article-title":"Withdrawn - a resource for withdrawn and discontinued drugs","volume":"44","author":"Siramshetty","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B243","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/TCRM.S4438","article-title":"Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain","volume":"5","author":"Smith","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"B244","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.toxicon.2005.04.012","article-title":"Effects of scorpion venom bioactive polypolypeptides on platelet aggregation and thrombosis and plasma 6-keto-PG F1alpha and TXB2 in rabbits and rats","volume":"46","author":"Song","year":"2005","journal-title":"Toxicon"},{"key":"B245","unstructured":"SOR-C13 clinical development program -\u00a0A first-in-class drug candidate in development for the treatment of solid-tumor cancer2018"},{"key":"B246","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pain.2008.07.014","article-title":"Analgesic effect in rodents of native and recombinant Ph\u03b11\u03b2 toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom","volume":"140","author":"Souza","year":"2008","journal-title":"Pain"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/203943","article-title":"Fibrin sealant: The only approved hemostat, sealant, and adhesive - a laboratory and clinical perspective","volume":"2014","author":"Spotnitz","year":"2014","journal-title":"ISRN Surg."},{"key":"B248","first-page":"260","article-title":"Practical application of the protein C activator Protac from Agkistrodon contortrix venom","volume":"115","author":"Stocker","year":"1988","journal-title":"Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch."},{"key":"B249","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-3-642-66863-0_13","article-title":"Defibrinogenation with thrombin-like snake venom enzymes","volume-title":"Fibrinolytics and antifibrinolytics","author":"Stocker","year":"1978"},{"key":"B250","doi-asserted-by":"publisher","first-page":"e0006427","DOI":"10.1371\/journal.pntd.0006427","article-title":"In vitro assessment of cytotoxic activities of Lachesis muta muta snake venom","volume":"12","author":"Stransky","year":"2018","journal-title":"PloS Negl. Trop. Dis."},{"key":"B251","first-page":"24","article-title":"HPLC separation and determination of bufadienolide in cinobufacini injection","volume":"25","author":"Su","year":"2003","journal-title":"Chin. Tradit. Pat. Med."},{"key":"B252","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1568006043335754","article-title":"Alpha-fibrinogenases","volume":"4","author":"Swenson","year":"2004","journal-title":"Curr. Drug Targets Cardiovasc. Haematol. Disord."},{"key":"B253","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/B978-0-12-382219-2.00205-2","article-title":"Fibrolase","volume-title":"Handbook of proteolytic enzymes","author":"Swenson","year":"2013"},{"key":"B254","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/s0890-6238(01)00161-7","article-title":"Enalapril: pharmacokinetic\/dynamic inferences for comparative developmental toxicity - A review","volume":"15","author":"Tabacova","year":"2001","journal-title":"Reprod. Toxicol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"C125","DOI":"10.1159\/000232592","article-title":"Drug development: from concept to marketing","volume":"113","author":"Tamimi","year":"2009","journal-title":"Nephron Clin. Pract."},{"key":"B256","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","article-title":"Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1 R14A and its PEGylated analog","volume":"180","author":"Tanner","year":"2017","journal-title":"Clin. Immunol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000048067","article-title":"Snake venom activators of factor X: an overview","volume":"31","author":"Tans","year":"2001","journal-title":"Haemostasis"},{"key":"B258","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1002\/jcb.27943","article-title":"New generation CPPs show distinct selectivity for cancer and noncancer cells","volume":"120","author":"Tansi","year":"2019","journal-title":"J. Cell Biochem."},{"key":"B259","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.112.191890","article-title":"Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease","volume":"342","author":"Tarcha","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B260","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1517\/14656566.3.8.1199","article-title":"Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb\/IIIa","volume":"3","author":"Tcheng","year":"2002","journal-title":"Expert OpinPharmacother."},{"key":"B261","doi-asserted-by":"crossref","first-page":"17471","DOI":"10.1016\/S0021-9258(19)77860-0","article-title":"The factor V-activating enzyme (RVV-V) from Russell\u2019s viper venom. Identification of isoproteins RVV-V alpha, -V beta, and -V gamma and their complete amino acid sequences","volume":"263","author":"Tokunaga","year":"1988","journal-title":"J. Biol. Chem."},{"key":"B262","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","article-title":"Platelet GPIIb-IIIa blockers","volume":"353","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"B263","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3390\/molecules22081282","article-title":"New insights in the design of bioactive peptides and chelating agents for imaging and therapy in oncology","volume":"22","author":"Tornesello","year":"2017","journal-title":"Molecules"},{"key":"B264","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/bja\/81.1.69","article-title":"Epibatidine and pain","volume":"81","author":"Traynor","year":"1998","journal-title":"Br. J. Anaesth."},{"key":"B265","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40264-018-0732-5","article-title":"The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand","volume":"42","author":"Trifiro","year":"2019","journal-title":"Drug Safe"},{"key":"B266","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/phar.1962","article-title":"Lixisenatide, a once-daily prandial glucagon-like peptide-1 receptor agonist for the treatment of adults with type 2 diabetes","volume":"37","author":"Trujillo","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B267","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bcp.2013.08.001","article-title":"Neuronal nicotinic receptors as analgesic targets: it\u2019s a winding road","volume":"86","author":"Umana","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"B268","unstructured":"FDA approves Adlyxin to treat type 2 diabetes2016"},{"key":"B269","unstructured":"Drugs FDA: FDA approved drug products2020"},{"key":"B270","unstructured":"ClinicalTrials.gov - Find a study2020"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00423","article-title":"Animal toxins as comprehensive pharmacological tools to identify diverse ion channels","volume":"10","author":"Utkin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4331\/wjbc.v8.i1.4","article-title":"Modern trends in animal venom research - omics and nanomaterials","volume":"8","author":"Utkin","year":"2017","journal-title":"World J. Biol. Chem."},{"key":"B273","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1359\/JBMR.0301213","article-title":"Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease","volume":"19","author":"Valverde","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"B274","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/mol.112.078006","article-title":"Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells","volume":"82","author":"Varga","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"B275","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gene.2005.05.002","article-title":"A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome","volume":"355","author":"Veiga","year":"2005","journal-title":"Gene"},{"key":"B276","first-page":"371","article-title":"\u201cLonomia obliqua venom: pharmaco-toxicological effects and biotechnological perspectives,\u201d","volume-title":"Animal toxins: state of the art - perspectives in health and biotechnology","author":"Veiga","year":"2009"},{"key":"B277","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"B278","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1016\/j.bmc.2016.08.023","article-title":"ArgTX-636, a polyamine isolated from spider venom: A novel class of melanogenesis inhibitors","volume":"24","author":"Verdoni","year":"2016","journal-title":"Bioorgan. Med. Chem."},{"key":"B279","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2016.11.015","article-title":"NaV1.7 as a pain target - From gene to pharmacology","volume":"172","author":"Vetter","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0257-7","article-title":"Kv1.3 channel blockade with the Vm24 scorpion toxin attenuates the CD4+ effector memory T cell response to TCR stimulation","volume":"16","author":"Veytia-Bucheli","year":"2018","journal-title":"J. Cell Commun. Signal"},{"key":"B281","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.2174\/092986712804485818","article-title":"Update of peptides with antibacterial activity","volume":"19","author":"Vila-Farres","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"B282","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1476-5381.2012.02082.x","article-title":"Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain","volume":"167","author":"Vink","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B283","unstructured":"Medicon ValleyScandinaviaVivostat autologous fibrin sealant2018"},{"key":"B284","doi-asserted-by":"publisher","first-page":"16862","DOI":"10.1074\/jbc.M113.464750","article-title":"Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin","volume":"288","author":"Vu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B285","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","article-title":"Bivalent direct thrombin inhibitors: hirudin and bivalirudin","volume":"17","author":"Warkentin","year":"2004","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1055\/s-2005-917664","article-title":"Tropical marine neurotoxins: Venoms to drugs","volume":"25","author":"Watters","year":"2005","journal-title":"Semin. Neurol."},{"key":"B287","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jch.12237","article-title":"Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"16","author":"Weber","year":"2014","journal-title":"J. Clin. Hypertens."},{"key":"B288","doi-asserted-by":"publisher","first-page":"H71","DOI":"10.1152\/ajpheart.1993.264.1.H71","article-title":"Action of C-type natriuretic peptide in isolated canine arteries and veins","volume":"264","author":"Wei","year":"1993","journal-title":"Am. J. Physiol."},{"key":"B289","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3760\/cma.j.issn.0366-6999.2010.05.016","article-title":"A multicenter, phase III trial of hemocoagulase Agkistrodon: hemostasis, coagulation, and safety in patients undergoing abdominal surgery","volume":"123","author":"Wei","year":"2010","journal-title":"Chin. Med. J. (Engl)"},{"key":"B290","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V55.5.811.811","article-title":"Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation","volume":"55","author":"Weinger","year":"1980","journal-title":"Blood"},{"key":"B291","doi-asserted-by":"publisher","first-page":"412","DOI":"10.7150\/thno.7324","article-title":"Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist - from mice to men","volume":"4","author":"Wieser","year":"2014","journal-title":"Theranostics"},{"key":"B292","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/s0041-0101(01)00277-x","article-title":"The venom optimisation hypothesis: a spider injects large venom quantities only into difficult prey types","volume":"40","author":"Wigger","year":"2002","journal-title":"Toxicon"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.3390\/ht7030019","article-title":"Venomics: A mini-review","volume":"7","author":"Wilson","year":"2018","journal-title":"High Throughput"},{"key":"B294","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/ncpcardio0277","article-title":"Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention","volume":"2","author":"Wong","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"B295","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/dom.13056","article-title":"Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes","volume":"20","author":"Wysham","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047375","article-title":"Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research","volume":"7","author":"Xie","year":"2012","journal-title":"PloS One"},{"key":"B297","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.mehy.2013.04.038","article-title":"Efficacy and safety of Huachansu combined with chemotherapy in advanced gastric cancer: a meta-analysis","volume":"81","author":"Xie","year":"2013","journal-title":"Med. Hypotheses"},{"key":"B298","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5414\/CP202296","article-title":"Hemocoagulase agkistrodon-induced anaphylactic shock: A case report and literature review","volume":"54","author":"Xu","year":"2016","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"B299","first-page":"19","article-title":"Functional analysis of a gene encoding a chlorotoxin-like peptide derived from scorpion toxin","volume":"21","author":"Yang","year":"2005","journal-title":"Chin. J. Biochem. Mol. Biol."},{"key":"B300","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40265-019-01078-0","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban in acute ischemic stroke","volume":"79","author":"Yang","year":"2019","journal-title":"Drugs"},{"key":"B301","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.febslet.2004.06.060","article-title":"Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris","volume":"571","author":"You","year":"2004","journal-title":"FEBS Lett."},{"key":"B302","doi-asserted-by":"publisher","DOI":"10.1088\/1748-6041\/9\/2\/025002","article-title":"The effective control of a bleeding injury using a medical adhesive containing batroxobin","volume":"9","author":"You","year":"2014","journal-title":"BioMed. Mat."},{"key":"B303","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090576","article-title":"Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats","volume":"9","author":"Zambelli","year":"2014","journal-title":"PloS One"},{"key":"B304","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1517\/14656566.8.8.1147","article-title":"The role of eptifibatide in patients undergoing percutaneous coronary intervention","volume":"8","author":"Zeymer","year":"2007","journal-title":"Expert Opin. Pharmacother."},{"key":"B305","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clindermatol.2009.05.013","article-title":"Cosmeceuticals and peptides","volume":"27","author":"Zhang","year":"2009","journal-title":"Clin. Dermatol."},{"key":"B306","doi-asserted-by":"publisher","first-page":"183","DOI":"10.13918\/j.issn.2095-8137.2015.4.183","article-title":"Why do we study animal toxins","volume":"36","author":"Zhang","year":"2015","journal-title":"Zool Res."},{"key":"B307","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/toxins7051749","article-title":"Toxins targeting the Kv1.3 channel: Potential immunomodulators for autoimmune diseases","volume":"7","author":"Zhao","year":"2015","journal-title":"Toxins"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T18:49:29Z","timestamp":1723315769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":307,"alternative-id":["10.3389\/fphar.2020.01132"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01132","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,24]]},"article-number":"1132"}}